74 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
require kidney replacement therapy (KRT) survive, with those surviving at risk of long-term, life-threatening conditions such as chronic kidney disease … and chronic indications.
In September 2023 the Company received Breakthrough Device Designation for the SCD for use in cardiorenal syndrome
8-K
EX-99.1
mp3kipt9 5p303
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
424B3
va2960
5 Mar 24
Prospectus supplement
5:08pm
424B3
8vdf jupnocwgjnzx
5 Mar 24
Prospectus supplement
4:59pm
424B3
qrryvjp
5 Mar 24
Prospectus supplement
4:57pm
8-K
EX-99.1
ixp7qhwnnpukh45o3493
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
424B5
73broel5ag1rxn
30 Jan 24
Prospectus supplement for primary offering
10:55am
S-3
vb182n
1 Dec 23
Shelf registration
4:06pm
8-K
EX-99.1
ywzhzlvf19s
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
424B3
ft6iv6usc0bouz3t
6 Oct 23
Prospectus supplement
1:08pm